Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.81 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.79 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.79 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.78 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17371120 | 0.91 | TSHR (0.85) | TSHRADORA3CYP3A4NFKB1 | |
| SCHEMBL13975993 | 0.91 | TSHR (0.85) | TSHRADORA3CYP3A4NFKB1 | |
| SCHEMBL4542860 | 0.91 | TSHR (0.85) | TSHRADORA3CYP3A4NFKB1 | |
| SCHEMBL21139455 | 0.91 | TSHR (0.85) | TSHRADORA3CYP3A4NFKB1 | |
| SCHEMBL13975995 | 0.84 | SLC29A1 (0.67) | ADORA3ADORA1 | |
| SCHEMBL16585410 | 0.84 | ADORA3 (0.85) | TSHRADORA2BADORA2AADORA3ADORA1 | |
| SCHEMBL13834762 | 0.83 | SLC29A1 (0.67) | ADORA3ADORA1 | |
| SCHEMBL17825909 | 0.83 | SLC29A1 (0.78) | ADORA3ADORA1 | |
| SCHEMBL640071 | 0.83 | SLC29A1 (0.78) | ADORA3ADORA1 | |
| SCHEMBL21139431 | 0.83 | SLC29A1 (0.78) | ADORA3ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |